RLYB: Rallybio Kompaniya qiymatining sof foydaga nisbati

Rallybio (RLYB) korporativ emblemasi va logotipi

Narx harakati Rallybio Corporation (RLYB) modelini baholashga yordam beradi, bunda moddalar yaratish tashqi pudratchilarga topshirilgan va joriy ko'rsatkich 3.10 darajasida turibdi. Narx dinamikasi makroiqtisodiy omillarni e'tiborsiz qoldirgan holda, prenatal va gematologik patologiyalar sohasidagi testlar natijalariga tayanadi. Jarayonlarni kamyob kasalliklarga qarshi kurashish uchun qimmatli tibbiy aktivlarni tanlay oladigan ekspertlar jamoasi boshqaradi.

RLYB Rallybio Corp: Narx-foyda koeffitsiyenti 04.07.2022 - 15.11.2026 oraligʻida

Rallybio Corp (RLYB) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:Rallybio Corp - RLYB
Rallybio yetakchi tovari

Yuqori sifatli portfelni shakllantirish uchun men kompaniyaning bozor qiymati va uning yillik sof foydasi nisbatini tahlil qilish orqali aktivlarning haddan tashqari qimmat baholanganligini baholash vositasi sifatida P/E ko'rsatkichidan foydalanaman. Rallybio Corporation (RLYB) holatida, rahbariyatning immunologiya sohasidagi ilmiy tajribasi va Johnson & Johnson bilan hamkorligini hisobga olgan holda, narx-foyda tendentsiyasi joriy moliyaviy natijalarga nisbatan kamyob kasalliklar dori vositalarini tijoratlashtirishga bo'lgan bozor kutuvlarini aks ettiradi.

Raqobatdosh kompaniyalar tahlili

HLN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalizatsiyaning foydaga nisbati|AMRX: Narx-foyda koeffitsiyenti|Perrigo - Bozor narxining sof foydaga nisbati|ALVO: P/E multiplikatori|Liquidia Technologies - Kompaniya qiymatining sof foydaga nisbati|GLPG (Galapagos N.V.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati anipharmaceuticals.com ANIP|Narxning foydaga nisbati MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Pacira BioSciences, Inc. PCRX|P/E multiplikatori ARS Corp SPRY|Theravance Biopharma - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - P/E multiplikatori|Narx-foyda multiplikatori SXTC (China SXT Pharmaceuticals)|P/E multiplikatori EPRX|P/E multiplikatori bioharvest.com (BHST)|Narxning foydaga nisbati Invizyne Technologies EXOZ|ORMP: Narx-foyda multiplikatori|ENTX: Narx-foyda koeffitsiyenti|HYFT: Narxning foydaga nisbati|ABVC BioPharma Inc. (ABVC) - Narxning foydaga nisbati|cumberlandpharma.com (CPIX) - P/E multiplikatori|QNTM (Quantum BioPharma) - P/E multiplikatori|FGEN: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TELO|P/E multiplikatori Rani Therapeutics Holdings (RANI)|P/E multiplikatori SNYR (Synergy CHC Corp)|Lexaria Bioscience (LEXX) - Kapitalizatsiyaning foydaga nisbati|PULM - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pheton Holdings PTHL|APM (Aptorum) - Narx-foyda koeffitsiyenti|Lyra Therapeutics, Inc. (LYRA) - P/E multiplikatori|IBO (impactbiomedinc.com) - P/E multiplikatori|TNFA (TNF Pharmaceuticals) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati cbdmd.com (YCBD)|Biznesning o‘zini qoplash muddati PainReform Ltd|P/E multiplikatori CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalizatsiyaning foydaga nisbati|OPTN - Narxning foydaga nisbati|Pieris Pharmaceuticals - Bozor narxining sof foydaga nisbati|PROC (Procaps Group) - Narx-foyda koeffitsiyenti|PTPI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Qilian International Holding Group Limited|SLRN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TFFP (TFF Pharma)